The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries.
The key market players for APAC Cancer Diagnostics Market are listed below:
• Hoffman-La Roche Ltd
• Abbott Laboratories Inc
The market is further segmented into:
• End User
The APAC cancer diagnostics market is segmented on the basis of technology, application and geography. The APAC cancer diagnostics market is segmented into 2 types- platform based and instrument based.
In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.
Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the APAC Cancer Diagnostics Market is segmented into 11 geographical regions, such as,
• South Korea,
• Rest of APAC
Covered in this report
The report covers the present scenario and the growth prospects of the APAC Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.